Shenzhen Kangtai Biological Products Co Ltd (300601) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shenzhen Kangtai Biological Products Co Ltd (300601) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥405.44 Million ≈ $59.33 Million USD) by net assets (CN¥9.61 Billion ≈ $1.41 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shenzhen Kangtai Biological Products Co (300601) defensive interval to measure how many days the company can operate on defensive assets alone.

Shenzhen Kangtai Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shenzhen Kangtai Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Kangtai Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Kangtai Biological Products Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
FAIRFAX INDIA HLDGS F:F5X	0.007x
Dgb Financial KO:139130	0.001x
Mesoblast Ltd AU:MSB	-0.007x
American Superconductor Corporation NASDAQ:AMSC	0.017x
Vietnam National Petroleum Group VN:PLX	0.325x
Surgery Partners Inc NASDAQ:SGRY	0.024x
Horace Mann Educators Corporation NYSE:HMN	0.042x
EMBOTELL. ANDINA ADR A/6 F:AKOA	N/A

Annual Cash Flow Conversion Efficiency for Shenzhen Kangtai Biological Products Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Shenzhen Kangtai Biological Products Co (300601) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥9.63 Billion ≈ $1.41 Billion	CN¥635.57 Million ≈ $93.00 Million	0.066x	+5.68%
2024-12-31	CN¥9.66 Billion ≈ $1.41 Billion	CN¥603.25 Million ≈ $88.27 Million	0.062x	-42.33%
2023-12-31	CN¥9.54 Billion ≈ $1.40 Billion	CN¥1.03 Billion ≈ $151.18 Million	0.108x	+78.28%
2022-12-31	CN¥8.99 Billion ≈ $1.31 Billion	CN¥545.70 Million ≈ $79.85 Million	0.061x	-66.31%
2021-12-31	CN¥9.17 Billion ≈ $1.34 Billion	CN¥1.65 Billion ≈ $241.78 Million	0.180x	+205.85%
2020-12-31	CN¥7.46 Billion ≈ $1.09 Billion	CN¥439.85 Million ≈ $64.36 Million	0.059x	-67.90%
2019-12-31	CN¥2.75 Billion ≈ $403.03 Million	CN¥505.70 Million ≈ $74.00 Million	0.184x	+0.25%
2018-12-31	CN¥1.84 Billion ≈ $268.83 Million	CN¥336.48 Million ≈ $49.24 Million	0.183x	+27.39%
2017-12-31	CN¥1.07 Billion ≈ $156.72 Million	CN¥153.98 Million ≈ $22.53 Million	0.144x	+34.92%
2016-12-31	CN¥735.00 Million ≈ $107.55 Million	CN¥78.32 Million ≈ $11.46 Million	0.107x	-75.18%
2015-12-31	CN¥647.12 Million ≈ $94.69 Million	CN¥277.85 Million ≈ $40.66 Million	0.429x	+123.70%
2014-12-31	CN¥583.81 Million ≈ $85.43 Million	CN¥112.06 Million ≈ $16.40 Million	0.192x	+170.74%
2013-12-31	CN¥372.17 Million ≈ $54.46 Million	CN¥26.38 Million ≈ $3.86 Million	0.071x	+482.01%
2012-12-31	CN¥431.21 Million ≈ $63.10 Million	CN¥5.25 Million ≈ $768.62K	0.012x	--

About Shenzhen Kangtai Biological Products Co Ltd

SHE:300601 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.88 Billion

CN¥12.87 Billion CNY

Market Cap Rank

#6506 Global

#1402 in China

Share Price

CN¥11.52

Change (1 day)

-0.17%

52-Week Range

CN¥11.49 - CN¥20.49

All Time High

CN¥148.10